HIGHLIGHTS
SUMMARY
In the context of randomized clinical trials, subcutaneous implantable cardiac defibrillators (S-ICDs) are non-inferior to transvenous ICDs (T-ICDs) concerning device-related complications or inappropriate shocks in patients with an indication for defibrillator therapy and not in need of pacing. The authors aimed at describing the clinical features of patients who underwent S-ICD implantation in the clinical practice, as well as the ICD-related complications and the inappropriate therapies among S-ICD vs. T-ICD recipients during a long-term follow-up. All patients undergoing ICD, both S-ICD and TV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.